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Abstract
The Effects of Cholinergic Antagonist and Enhancers Spatial Learning and
Memory in the Morris Water Maze in Mice
To investigate the cholinergic system’s role In learning and memory, I.
utilized the Morris water maze (MWM) task, which tests spatial ability. Subjects
must locate a submerged, hidden platform using the various distal cues around
the room to orient themselves in space to find the escape platform. The
cholinergic system regulates spatial learning and memory necessary for tasks
such as the MWM and also plays a role in locomotor activity. I performed a pilot
study to demonstrate that outbred strains of mice perform the MWM task
effectively. I then used an outbred strain of mice, Swiss Webster, in the MWM to
test the effects of a purported cholinergic enhancer and standard anticholinergics
on spatial memory and on locomotor activity. Anticholinergics hinder an animal’s
ability to perform spatial learning activities by blocking muscarinic acetylcholine
(ACh) receptors In the neural synapses. In Experiment One, I tested the effects
of the anticholinergic. Scopolamine (Scop), thereby inhibiting effects of ACh in
the neural synapses. To attempt to reverse the effects of Scop, we used
Schlsandrol A (SchisA), a natural acetylcholinesterase inhibitor. The drug Is
thought to Improve memory formation by inhibiting the breakdown of ACh In the
synapses, which increases ACh’s effect time for synaptic transmission. I found
that SchisA did not reverse memory deficits Induced by Scop, In fact, the
combined drug treatment group did worse than all other groups. In addition.
IV
Scop did not have as dramatic deficits on learning as expected; therefore, in
Experiment Two, I tested the effects of Scop at a higher dosage along with
another anticholinergic, Atropine Sulfate (AS), in the MWM. Both anticholinergics
Induced learning and memory impairments; however, they Induced opposite
locomotion effects with Scop Increasing and AS decreasing locomotion. Based
on these results, I do not recommend further research into the possibility of
SchlsA being a treatment option for ailments involving reduced cholinergic
activity, such as Alzheimer’s disease. Additionally, the higher dosage of Scop
should be used in studies where a learning deficit is desired, while the dosage of
AS I used should be avoided In mice due to its substantial peripheral effects.
v
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Acetylcholine (ACh) plays many important roles within the body as it is
involved in muscle contraction; autonomic nervous system function; and, in the
central nervous system, it plays a role in plasticity, learning, and memory (Uzuz
et al. 2004, Dani et al. 2007, Janis et al. 1998, Hughes et al. 1951, Changeux
1993, Hebb 1957, Kohler et al. 1996, Deiana et al. 2009, Kuc et al. 2006,
Sutherland et al. 1982, Whishaw 1985, Bilbo et al. 1999, Day et al. 1996, Origlia
et al. 2008). The receptor types of the cholinergic system are categorized into
two families; nicotinic and muscarinic, both of which are ion channels activated
by ACh (Hulme et al. 1993, Origlia et al. 2008, Foldale et al. 2006). Nicotinic
receptors are also opened by nicotine, and muscarinic receptors (mAChR) are
also opened via muscarine (Hulme et al.1993, Uzum et al. 2004, Dani et al.
2007, Foldale et al. 2006).
The mAChRs include five subtypes (Ml - M5), and most muscarinic
antagonists affect all five (Hulme et al. 1998, Caulfield et al.1998, Wess et al.
2003). The subtypes have some unique and some overlapping functions that
could all be altered by such antagonists or agonists.
The Ml subtype is found In the brain and exocrine glands, and probably
serves a role In higher cognition such as learning and memory (Hulme et al.
1993, Wess et al. 2003, Fisher et al. 1996). The high density of this receptor
type in the hippocampus and forebrain, structures involved in learning and
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memory processes, supports the idea that the M1 receptors are involved in
learning (Anagnostaras et al. 2003). In addition, learning and memory processes
that require the use of the hippocampus or the cerebral cortex are affected by the
absence of M1 receptors (Wess et al. 2004, Miyakawa et al. 2001, Matsui et al.
2004, Anagnostaras et al. 2003). Lastly, Ml receptor knock-out mice, also show
increased locomotor activity (Gerber et al. 2001, Miyakawa et al. 2001, Wess et
al. 2004) possibly related to cortical motor impairments or to some peripheral
actions of this receptor type. M2 receptors are found largely in cardiac and
smooth muscle tissue (Hulme et al. 1998, Stojkovic-Andjelkovic et al. 2010).
When blocked, M2 receptors cause a decrease in contractile force and slow
heart rate (Caulfield et al. 1993 and 1998). In vascular smooth muscle, M3
receptors create relaxation (Caulfield et al. 1993 and 1998, Eglen et al. 1990).
Additionally, M3 receptor knock-out mice show decreased food Intake and
salivation (Yamada et al. 2001, Caulfield et al. 1998). M4 receptors are found
mainly in neural tissue (Hulme et al. 1998). Inhibition of the M4 receptor causes
a decrease in activity of adenylyl cyclase, which decreases calcium influx into the
cell and hinders neurotransmission (Hulme et al. 1998). M4 Inhibition also has
repercussions for locomotor activity (Gomeza et al. 1999). The final subtype,
M5, Is less studied but has effects in blood flow regulation and reward systems
(Wess et al. 2004, Yamada et al. 2001, Basile et al. 2002, Fink-Jensen et al.
2003). Because most mAChR antagonists inhibit all subtypes of receptors,
effects in both the central and peripheral nervous system occur, including effects
on locomotion, blood flow, and heart rate (Gomeza et al. 1999, Klinkenberg et al.
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2010). Although blocking these receptors will induce some side effects because
they act on all receptor subtypes, such drugs are still widely utilized because they
are an excellent means to mimic learning and memory deficits caused by ACh
depletion in the brain. Brain muscarinic receptors are depleted In several
neurological disorders, Including Alzheimer’s, so the prominent role of ACh in
learning and memory has been well studied.
Generally, the cholinergic system seems to be important in learning
flexible associations and resisting stereotypical behaviors, but it does not seem
to be necessary to perform simple associations such as visual discrimination or
cue guided responses to a goal, at least In mammals (Andrews et al. 1992,
Harder et al. 1998). In reptiles and amphibians, ACh may also play a role in
forming simple associations (Bilbo et al. 2000). The role of ACh in learning in
birds has not been extensively explored (Kohler et al. 1996) but is currently being
expanded (Coltharp et al. 2010).
Simple associations, the type of learning not typically affected by ACh
antagonist, can be defined as those forms of learning that do not require
complex, flexible associations or conscious recall, and is often called procedural
learning. For example, learning to ride a bike, learning to associate a bell with
dinnertime and salivating in response to the bell, and teaching a cat to use a
human toilet are all forms of procedural learning (Pavlov 1906, Purves et al.
2004, Bear et al. 2007). By contrast, working memory, spatial learning, and the
formation of autobiographical memories, involve complex, flexible associations
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and require cortical and hippocampal regions (Olton et al. 1979, Hodges et al.
1996), brain regions that contain abundant ACh receptors.
Multiple tests have been designed to examine various forms of complex
memory. The radial-arm maze is a test that requires working memory; however,
it can also be used to test spatial reference memory. To demonstrate working
memory, rewards are located at the end of each arm of the maze, which are
paths leading off the center of the maze. If an animal revisits an arm already
visited in that trial, and those devoid of a food reward, these entries are
considered working memory errors (Hodges et al. 1996, Kuc et al. 2006).
Demands for reference memory can be made by consistently baiting a subset of
the arms across trials. The number of times a mouse enters an arm that was
never baited show reference memory errors while revisits Into previously baited
or un-bated arms are working memory errors (Hodges et al. 1996, Kuc et al.
2006). Because animals can use simple associations rather than reference
memory to identity baited arms such as local cues on the walls of the maze and
because some forms of working memory do not require complex associations
and do not involve the hippocampus (Olton et al. 1979, Jarrard 1978, Kimble et
al. 1970) whereas others may (Olton et al. 1979), it Is best to use a task that
requires only reference learning when attempting to study complex forms of
learning.
A special type of reference memory, spatial memory, requires learning a
set location over trials. Spatial memory can be tested in the radial-arm maze, but
It is not the only learning used to solve the task. A test that can differentiate
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when spatial memory versus other types of learning is used to solve the task is
the Morris water maze (MWM, Morris 1981). The MWM involves the subject
locating a hidden platform, submerged underwater, using only distal cues around
the room. Since there are no local cues to identify the platform, simple approach
or avoidance of visual cues cannot be used to solve the task. Once the subject
learns to locate the platform over trials, the platform Is taken out of the pool of
water by the experimenter during a “probe trial" and mice are allowed to swim for
a specific time Interval. Learning of the platform location using spatial cues is
confirmed during this “probe” trial, by the animal searching for the platform in the
previously correct location of the platform. Because the MWM probe indicates
spatial learning has taken place, we can be certain we are engaging complex
associations of spatial learning.
Using the tests previously described and others while also
pharmacologically decreasing ACh’s ability to bind to muscarinic receptors, we
observe a sharp deficit in the ability to learn new tasks involving spatial-working
memory as well as other complex forms of learning and memory (Brufani et. al
1987, Egashira et al. 2008, Kohler et al. 1996, Deianna et al. 2009, Kuc et al.
2006, Sutherland et al. 1982, Whishaw 1985, Day et al. 1996). When rats were
given Scopolamine (Scop) in the radial-arm maze, working memory errors and
reference memory errors Increased while correct choices decreased compared to
saline-injected controls (Klinkenberg et al. 2010, Masuoka et al. 2006, Egashira
2008). In the Morris water maze (MWM), many species have been tested to
determine ACh’s role in spatial learning and memory. In mice and rats, duration
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to the hidden platform, distance traversed to reach the platform, time spent in the
previous location of the platform during the probe trial when the platform is
removed, and thigmotaxis—clinging to the walls to find escape—increases in
Scop and Atropine Sulfate (AS) treated subjects when compared to controls
(Deianna et al. 2009, Klinkenberg et al. 2010, Berger-Sweeney et al. 1995, Day
et al. 1996, Whishaw et al. 1985, Sutherland et al. 1982). ACh has also been
shown to play a role in holeboard discrimination, which involves placing mice in a
square chamber to learn several “reward” holes, which contain a food reward.
Similar to the MWM, this task requires spatial reference memory due to the
presence of distal cues and absence of local cues. Mice given Scop were unable
to remember reward locations and revisited previous reward locations when
compared to controls (Kuc et al. 2006). Additionally ACh deficits reduce flexibility
and plasticity in learning and in natural behaviors. Rats administered AS were
unable to change directions for escape in a tube and remained trapped on a
wooden block without appearing to realize their ability to jump from it (Schallert et
al. 1980).
Frogs do not appear capable of learning reference memory in the MWM,
but compared to the frogs given the vehicle, AS treatment slowed learning how to
escape to a visible platform (Day et al. 1996). Additionally, when homing
pigeons are given a dose of Scop prior to homing, they have Increased scatter in
vanishing bearings compared to controls signifying ACh Is important for neural
processes associated with spatial navigation used during homing (Kohler et al.
1996). These studies in which drugs blocked mAChRs support the theory that
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ACh plays a role in many different types of learning that involve flexible
responses to a novel situation.
We can also examine the effects of ACh in learning and memory by
enhancing its function or prolonging its effects by preventing its breakdown in the
synaptic cleft. This is achieved by disrupting the enzyme acetylcholinesterase
(AChE), which breaks down ACh to render it nonfunctional (Dani et al. 2007,
Descarries et al. 1997, Pepeu et al. 2010, Grisaru et al. 1999, Egashira et al.
2008, Wang et al. 2007, Bekker et al. 2007, Dokla et al. 1988). The use of drugs
that inhibit AChE prolong the time of affectivity of ACh at the synapse and cause
a reversal of memory impairments due to lesions of ACh-containing neural
regions or drugs that block mAChR (Grisaru et al. 1999, Egashira et al. 2008,
Wang et al. 2007, Dokla et al. 1988). In mice, Huperzine A, an AChE inhibitor,
has been shown to block the effects of Scop in a passive avoidance test, a task
that requires the animal to move from one distinct chamber to another to avoid a
shock (Wang et al. 2007). In the MWM, lesions of the nucleus basalis
magnocellularius, an area rich in ACh neurons, cause disturbances in
performance when compared to controls; however, when three AChE inhibitors,
physostigmine and two N,N-alkyl phenyl carbamate cholinesterase Inhibitors,
were administered performance In the task Improved (Dokla et al. 1988). When
administered Schizandrin, a purported AChE inhibitor, memory impairment in rats
caused by Scop was reversed in the eight-arm radial maze (Egashira et al.
2008). These studies suggest AChE inhibitors could curb the effects of
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cholinergic underactivity in aging and disease by prolonging the time ACh has to
act on neurons.
When the cholinergic system is damaged due to illness or natural aging,
we see many of the same deficits observed in animal studies using drugs that
block mAChR (Bartus et al. 1982). For example, in natural aging and in diseases
such as Alzheimer’s, characterized by short-term memory loss, a decrease in
cholinergic activity is observed (Bartus et al. 1982, Francotte et al. 2004, Davis et
al. 1978, Wang et al. 2007, Davies et al. 1976). Certain diseases can inhibit the
pathways of memory, and memory loss affects many different parts of the brain
as it progresses. When the brain receives Information about an event, the
formation and retention of that event depends on many brain regions that can
include: the hippocampus, entorhinal and perirhinal cortices, the prefrontal
cortex, the cingulate cortex, the neostriatum, and the cerebellum (Vorhees et al.
2006). One of the main impairments seen Involves  a deficit in complex cognition
including spatial learning. This Is likely because the central regions that allow for
these types of memories are brain regions that contain ACh, including the
hippocampus.
Because ACh plays an important role in memory and is depleted in aging
and disease, drugs that target the cholinergic pathway In hopes to reverse the
deficits seen In these ailments are essential. Schisandra chinensis, a fruit used
for centuries as a traditional Chinese remedy to relieve ailments, such as
coughing and Insomnia, and protect against disease, contains many compounds
of which several have been found to possess the ability to inhibit AChE function
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(Hung et al. 2007). Schizandrin is one of the drugs purported to act via this
mechanism. As previously described above, Egashira et al. (2008) found that
Schizandrin reverses the memory impairments induced by Scop. Additionally
gomisin A, another component from Schisandra chinensis, was found to reverse
Scop impairments In the passive avoidance test (Kim et al. 2006). I tested a
stereoisomer of Schizandrin, Schlsandrol A (SchisA), as a possible remedy In
ailments associated with a decrease In cholinergic activity. SchisA should work
very similarly to Schizandrin, though the mechanism of action for either of these
drugs is unknown. Egashira et al’s (2008) study suggests it counteracts the
effects of ACh antagonist, but tests have not shown AChE inhibition (Hung et al.
2007). If we can confirm the ability of this class of drugs to alter behavior, it will
suggest alternative pathways to alter ACh activity and prompt further biochemical
investigations of the kinetics of this molecule.
To study the effects of ACh in learning and memory, I compared the
effects of SchisA against that of Scop, a mAChR antagonist. Prior to the
experiment, I ran a pilot study involving two mouse species, an inbred strain,
C57BL/6 (C57), and an outbred strain, CD1, because differences in hippocampal
chemistry exist in different strains. I hypothesized that the C57 would learn the
task faster and more efficiently than CD1, but the outbred strain would learn the
task sufficiently so that a less expensive experimental model might be available
for further investigations Involving the MWM. Because the outbred CD1 strain
successfully learned the task, I chose to use another outbred mouse strain, the
Swiss Webster, in the experiments comprising this thesis as it has previously
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been shown to perform better than CD1 mice in test of spatial learning and
memory. In the experiments, I used the MWM to test the effects of SchisA and
Scop. I predicted that SchisA would reverse memory Impairments induced by
Scop in the MWM In mice and that SchisA alone would improve learning and
memory. I found mixed support for the hypothesis that SchisA improved learning
and memory and also did not see a profound deficit in our Scop treated mice in
the learning portion of the task though they were impaired in spatial memory as
shown in the probe trial. Because Scop did not impair the learning phase of the
first experiment, I conducted a follow-up Investigation with Swiss Webster mice to
test the effects of a higher dose of Scop and an additional anticholinergic, AS,
that Is also known to cause deficits In the MWM.  I hypothesized that the new
dosage of Scop would impair spatial learning ability, which would be comparable
to the deficit Induced by AS. This was confirmed.
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Pilot Study
To determine the abilities of Inbred versus outbred mice strains In the
Morris water maze (MWM) and to optimize the maze and software for future
studies, 1 conducted a pilot test Involving an Inbred strain of mouse, C57BL6
(C57) and an outbred strain, CD1. Inbred strains, compared to outbred strains,
are typically used for tasks Involving learning and memory due to particular
variations In neurochemistry and synaptic plasticity favoring these skills (Sunyer
et al. 2007). Genetic differences between the strains contribute to variation In
many characters Including basic physical features, brain morphology, and brain
chemistry. Neural differences can lead to specific behavioral differences
Including Increased or decreased anxiety levels and improved or Impaired
learning and memory (Nguyen et al. 2000). The Inbred mouse strain, C57BI./6
(C57) and the outbred mouse strain, CD1, have been compared to other mouse
strains In several types of mazes (Patil et al. 2009, Kuc et al. 2006, Sunyer et al.
2007). For example, Kuc et al. (2006) observed that CD1 mice committed more
working memory errors In the holeboard discrimination task described previously.
Additionally, Patil et al. (2008) observed that the C57 mice outperformed CD1
subjects in the Multiple T-maze, another apparatus designed to test spatial
learning. My experiment set out to ensure that both strain types would be
adequate for our experiments since outbred strains are typically less expensive.
I hypothesized that the C57 strain would outperform the CD1 strain in the spatial
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learning task, the MWM; however, the CD1 strain would perform the maze well
enough to be used in further research.
Materials and Methods
Animals
I used 7 - 8 week old, naive C57 and CD1 male mice. In each experiment.
6 mice of each strain were used, totaling 12 mice per experiment, with 24 mice
used overall. They were purchased from Harlan Laboratories and housed in
standard animal facilities at the University of Mississippi.
Both species were housed in Ancare "75" boxes with 75 in^ of floor space
(10” X 7.5” X 5”). The light cycle was 12/12 (6:00 am to 6:00 pm). Availability of
food and water was ad libitum. Mice habituated to their home cages for five days
after delivery. To allow mice to acclimate to the experimenter, I handled them for
two days prior to testing. Housing and all experimental procedures were
approved by the University of Mississippi Institutional Animal Care and Use
Committee (protocol #07-016).
Materials
For the water maze, I used a 114 cm circular galvanized cattle trough that
was painted white with epoxy paint. In the pool was a 71 cm high, 10 cm
diameter platform that was 1 cm beneath the water surface, and the water level
was 10 cm below the lip of the pool. To make the water opaque, I added 24 oz
of dried milk. The temperature of the water was kept at 24°C ± 2®C to ensure
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motivation to exit the pool without causing hypothermia. The cues available
included four unique, large posters on all four walls of the room. In addition, a
table, computer, and I remained in the same positions throughout testing after
placing the mouse In the pool. The maze was divided into quadrants labeled
using artificial cardinal coordinates: northwest (NW), northeast (NE), southwest
(SW), and southeast (SE) with release points centered within each quadrant
labeled: N, S, E, and W. I utilized an Imaging Source FireWire camera fed
directly Into EthoVIsion 7.0 software (Noldus Information Technology, Leesburg,
VA) to collect dependent variables.
Methods
Traditional Morris water maze
The platform was located In the center of the SE quadrant during all training
trials. This position was approximately 20 cm away from the pool’s edge, thus
the animal could not bump into it If it was swimming along the pool wall.
Before testing, subjects underwent one pre-training trial. The mice were
placed on the platform for thirty seconds. If the subject jumped off the platform
into the water, I guided the subject gently back to the platform for the remainder
of the 30 s trial.
Pre-Training Visual probe
Prior to spatial acquisition trials, I ran a visual platform probe. The platform
remained In the same position for the remainder of testing in the traditional MWM
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trials. For the single visible platform trial, I reduced the water level to 1 cm below
the platform, gently placed mice In the maze with their head facing the pool wall
at the West entry point, and gave them 60 s to find the visible platform. If the
mouse found the platform it was allowed to remain on the platform for 2 s, and
then I let It climb onto my hand and removed the mouse from the pool. A lack of
strain differences on the visual platform trials would suggest no discrepancies in
motor skills or visual abilities between strains.
Spatial training
During the five days of traditional spatial MWM training, each mouse
undenA^ent four, 60 s trials each day. The C57 strain of mouse is black while the
CD1 mice are white. EthoVision uses contrast to track animals in the maze. I
used a non-toxic black marker to draw a line down the back of the white CD1
mice to ensure visual detection against the white, milk-water background. To
equate conditions between strains, I also drew on the black C57 mice, but the
marks were not visible on the fur. I released mice from one of the four release
I
points with its head facing the wall. The order of the release points was
randomized with the constraint that all mice were released from all four points
each day. The order of release points was random each day but remained the
same for all mice dally. When the mouse located the platform, it was allowed to
rest on the platform for 2 s. If the mouse had not reached the platform by the
end of 1 min, I guided it gently to the platform and allowed it to remain on the
platform for 2 s. After each trial, the mouse was dried and returned to a holding
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cage and then the next mouse was tested. The inter-trial interval (ITI) was
approximately 20 min for each mouse. I repeated the procedure for five
consecutive days with the exception that on the fifth day, the fourth trial was
replaced with a no-platform "probe trial”.
No-platform probe trial
During the no-platform probe trial at the end of spatial acquisition, I
removed the platform from the pool and examined strain preference for the
previously correct quadrant (PCQ) and the previous platform location. A
preference for swimming in the PCQ and the previous area of the platform
Indicates spatial learning of the platform’s location. The mice were given 60 s to
explore the maze without the platform present. After 60 s had elapsed, they
were removed from the pool.
Four-trial matching to place
In addition to the traditional MWM, a new set of naive mice underwent
spatial matching to place (MTP) testing, which lasted six days. This form of
learning requires that an animal learn the location of an object in as little as one
trial (“one-trial learning”) and demonstrate this memory in a subsequent trial after
a brief delay (Collinson et al. 2006). As long as the delay is over a few seconds,
this type of memory, much like Identifying arms already entered In the radial-arm
maze, requires spatial working memory and uses the hippocampus (e.g. Olton et
al. 1979, Milner et al. 1998). In addition, this task requires that the mouse not
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perseverate on the previously learned location when the platform is switched to a
new location, a type of flexibility requiring the hippocampus (Collinson et al.
2006). In my version of this procedure, I used the same MWM apparatus and
procedure; however, the position of the platform changed dally but not trial-to-
trlal.
Pre-training visual probe trial and training
On the first day, subjects performed the visible probe trial as in the standard
MWM along with three, 60s MTP trials with the hidden platform. Thus, the pre-
MTP visual probe replaced trial one on day one.
The platform remained in the same position for both the visual and hidden
platform trials on day one. For the following five days, mice underwent four, 60 s
trials with the platform in a new position dally. As In the traditional MWM, I
placed mice gently In the pool with their heads facing one of the four starting
points. Each of the four starting points was used daily in a randomized order.
Unlike the spatial reference trials, trials for one mouse were not interleaved with
trials for the other mice. Instead, each mouse performed its 4 trials consecutively
with a 30 s ITI. After testing the mice were dried off and placed In a holding cage
until testing of all mice was complete.
Post-training visual probe trial
After spatial MTP trials, I ran another visual probe task on day seven. I
used the same methods from the previous two visual probes with the exception
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that mice ran four visible platform trials with an inter-trial Interval (ITI) of 20 mins.
Additionally, I placed a red-colored flag (2 in x 1 1n) on top of the platform to
provide a more salient visual cue for the goal than the platform 1 cm above the
water surface. Visual platform was placed In the NW quadrant, which was
different from the last day of MTP training.
Data collection and statistical analysis
Traditional Morris water maze
I analyzed the five days of regular trials using  a repeated measures general
linear model that Is identical to a repeated measures analysis of variance
(ANOVA) but allows for a multivariate version of the repeated measures in cases
where there are violations of sphericity among days. Using EthoVIsion (Noldus
Information Technology), I collected the time to reach the platform, distance
swam to reach the platform, and swim velocity. For the no-platform probe trial, I
collected the number of times the mouse crossed the previously correct platform
area and the time and distance In the previously correct quadrant (PCQ) as well
as swim velocity. I performed a one-way ANOVA to compare the time and
distance swam among the four quadrants during the probe for each strain
separately to determine If either strain had a spatial bias for the PCQ. To
analyze the visible probe trial, I used a t-test to compare distance, velocity, and
latency to reaching the platform between strains. All statistics were performed
using SPSS Statistics 19.0.0.
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Four-trial matching to place
I collected the same dependent variables as for the standard MWM. I
averaged trial three and four for all days since  I only ran three trials on day one
due to the replacement of trial one with the visual platform probe trial. I used a
repeated measures ANOVA with trials nested within days to examine strain
differences in how well they learned the new platform placement each day.
Significant effects for trials were followed by planned comparisons to compare
the weighted performance of the first trial with performance on the second and
last two trials. In other words, trial one versus trial two and the average of trial
three and four were compared In the contrasts. A second planned comparison
contrasted the performance on trial one and two versus the average of the last
two trials. For these analyses I used SuperAnova (Version 1.11; Abacus
Concepts, Berkeley, CA). If the strains learned the goal location in one trial, they
should improve performance on the second and last two trials compared to the
first. If they learned the goal in two trials, then they should show improvement
between trial one and trial two versus the last two trials. For analysis of the
visual probes, I collected distance, velocity, and duration. I compared strains’
performance in the pre-MTP and post-MTP visual probe trial with a t-test (SPSS




Traditional Morris water maze
In the traditional MWM, C57 mice traversed a significantly shorter distance,
(F(1,10) = 7.62, p < 0.02), to reach the platform than the CD1 strain (Figure 1A).
In addition, the C57 were faster to reach the platform (F(1,10) = 7.09, p < 0.02,
Figure 1B) than the CD1 mice even though there was no significant difference in
swim speed (F(1,10) = 1.37, p < 0.27, Figure 1C).
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Figure 1. Average distance, duration, and velocity across days in the pilot study. Asterisks indicate
significance (p<0.02).
However, both strains did Improve performance over trials as evidenced by
reduced duration (F(4, 40) = 14.02, p < 0.0005), and distance swam to reach the
platform (F(4, 40) = 15.18, p < 0.0005), across days (Figure 1A & IB). During
the no-platform probe trial, C57 strain spent more time and frequented the PCQ
more often than GDI mice (Duration: F(1, 10) = 5.56, p < 0.04, Frequency of
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PCQ crosses: F(1,10) = 11.69, p < 0.01, Figure 2). The C57 strain preferred the
PCQ to an average of the other three quadrants in both duration spent in the
PCQ and in frequency of crosses (Duration: t(5) = 3.49, p = 0.02, Frequency of
Crosses: t(5) = 4.80, p = 0.002, Figure 2). The CD1 showed a bias for the PCQ
compared to the average of the other three quadrants in frequency of crosses
(t(5) = 2.85, p = 0.02) but not in duration (t(5)  = 1.66, p<0.08. Figure 2).
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Figure 2. Average duration and frequency of crosses in the PCQ verses the average of the other quadrants
during the no-platform probe. Asterisks indicate significance (p<0.02).
Since the C57 mice showed a greater bias to the PCQ and had a bias for the
PCQ for both duration spent in the PCQ and the times crossing the PCQ, it
suggests that they had more precise memory for the platform location than the
CD1 mice. Since the CD1 mice had some bias to the PCQ as well, they
appeared to have some basic learning of the MWM as well.
As in training and the no platform trial, the C57 strain’s performance differed
from the CD1 during the visual platform task with C57 have shorter distance
(t(10) = 3.23, p = 0.01, Figure 3A), and shorter duration to reach the platform
(t(10) = 3.91, p = 0.003, Figure 3B), suggesting the CDTs deficit compared to
C57 mice may be due to a deficiency in vision or motivation or general learning
rather than being spatial memory specific. Variance was significantly different
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between strains, suggesting caution in the use of parametric statistics. Mann-
Whitney U non-parametric test supported the parametric statistics with CD1
traversing a longer distance (p<0.006) and having  a faster velocity (p<0.01) to
reach the platform. Duration between the groups was not quite significant
(p<0.059). However, these results are difficult to interpret clearly because only 3
C57 mice and none of the CD1 mice found the visible platform within the 60 sec
time frame given.
Visual Probe; Distance to Reach
Platform





















Figure 3. Average distance and duration to the platform in the visual probe in the pilot study. Asterisks
indicate significance (p<0.01).
These results suggest the visual probe run prior to in MWM training was
overly difficult for both mice strains. Thus in the MTP experiment, I ran both a
pre-training visual probe as in this experiment and a post-training visual probe
after mice had some experience in the MWM, and I placed a flag on the visual
platform to indicate its location. I had originally run the visual trial in the standard
MWM only pre-training so as not to bias mice towards the location trained in
spatial trials during the standard MWM training.
Four-trial matching to piace
The nested ANOVA revealed that both groups improved over days of the
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experiment as shown by a significant decrease in distance among the trials
conducted each day (F(2,100) = 6.635, p < 0.006, Figure 4A). Also, both groups
learned the task as seen in the decrease in duration across days and a lack of a
significant day x strain interaction (F(1, 100) = 6.97, p<0.003. Figure 4B).
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Figure 4. Average distance and duration to the platform across days in MTP training. Asterisks indicate
significance (p<0.0006).
The C57 performed better than the GDI mice in both distance, (F(1,100) = 5.811,
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Figure 5. Average distance and duration to reach the platform across trials in MTP training. Asterisks
indicate significance (p<0.04).
Interestingly, in the duration to locate the platform, the C57 performed better than
the GDIs even on the first trials each day suggesting they were able to “forget’
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the previous days’ location better than did the CD1 mice (Figure 5B). The
planned comparisons examining Trial One versus Trial Two and the last two
trials (T1 vs. T2&T3) and Trials One and Two versus the last two trials (T1&T2
vs. T3) were run for both strains analyzed together first. These results suggested
the mice had one-trial learning by showing improvement in distance from T1 vs.
T2&T3 (F(1) = 4.25, p < 0.002, Figure 5A). However, neither strain alone
Improved significantly from T1 vs. T2&T3, suggesting a lack of power to detect
one trial learning in either strain. For two trial learning, both strains swam less
distance to the platform between T1&T2 vs. T3 (F(1) = 13.19 p < 0.05).
However, when I examined each strain Independently, I found that the CD1
showed no improvement across trials while C57 showed a trend for improvement
in decreasing distance from T1&T2 vs. T3 (F(1) = 3.67, p < 0.08, Figure 5A)
suggesting C57 but not GDI mice may have learned the task in two trials. Thus,
the C57 mice were faster and needed less distance than the GDI to locate the
platform in a spatial matching to sample task over the days of training, but even
the G57 did not show one trial matching to place learning and only showed a
trend for two-trial MTP.
During both the visual probe run prior to MTP testing and the visual probe
following MTP testing, no significance between groups was seen in distance,
duration, or velocity. Because mice were naive during the pre-MTP visual probe,
the lack of significance suggests the deficit seen in the GDI in the MTP task was
not in motivation or vision and the difference in the visual probe in standard
MWM was not in agreement with these results. The strain differences for the
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visual probe post-MTP in duration and in distance to the platform approached
significance (t(10) = 2.28, p=0.067, t(10) = 2.18, p=0.053). So, after learning the
location of a hidden platform, the GDIs were almost inferior to the C57s at
swimming to a visible platform with a flag on it. Since the GDIs were similar to
the G57s at finding a visible platform just above the water surface prior to
training, the post-training trend for differences suggest that the GD1 species may
not have been as flexible as the G57s in altering their previously learned
behavior of searching for a hidden platform. The G57s may need more trials to
show a separation in performance.
Discussion of Piiot Study
Because the G57 outperformed the GDI mouse strain, my results further
support the current literature that Inbred mice are better learners than outbred
mice strains. To my knowledge, this is the first study to compare the
performance of G57 and GD1 mice In a spatial matching to sample task. While
the G57 performed better than the GDI in this task, neither mouse strain learned
the task in a single trial as evidenced by a lack of significant improvement from
T1 vs. T2&T3. In addition, although both strains together showed a significant
Improvement from T1&T2 vs. T3 suggesting learning In two trials, neither strain
alone showed a significant improvement, though G57 did show a trend for
learning. This experiment is further evidence for superiority of G57 strain to the
GDI strain in a spatial learning task but suggests the MTP training Is too difficult
for either strain. However, my results do show that an outbred strain of mice can
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be utilized in the traditional MWM. Due to the expense involved in purchasing
inbred strains of mice, the results were useful in my next experiment when
choosing a research subject to undergo testing in the MWM.
In further experiments involving the traditional MWM, I decided to use the
outbred strain of mouse, the Swiss Webster, due to its similar or superior
performance to CD1 in reference and spatial memory tasks (Kuc et al. 2006,
Augustsson et al. 2004) and its common use in studies in the Center of
Biomedical Research Excellence in Natural Products Neuroscience (COBRE)
research facility at the University of Mississippi. Using this strain would allow us




In Experiment 1, 1 aimed to observe whether or not  a constituent of the
Schizandrin Berry {Schisandra chinensis), Schisandrol A (SchisA), counteracts
the effects of the muscarinic receptor (mAChR) antagonist, Scopolamine (Scop).
Previous evidence suggested that the stereoisomer of Schisandrol A,
Schizandrin, a purported Acetylcholinesterase (AChE) inhibitor, reversed memory
Impairments caused by Scop (Egashira et al. 2008). SchisA has not yet been
tested, but because these isomers may be bioactively similar, I hypothesized
SchisA would reverse memory Impairment and hyperactivity induced by Scop. If
this hypothesis is supported, it would suggest that SchisA should be further
tested as a treatment option for memory deficits seen in normal aging and
diseases such as Alzheimer’s.
Methods and Materials
Animals
Following the pilot study, I tested an outbred strain of mouse, Swiss
Webster, in the MWM. I used 7 - 8 week old naive, male mice. Twenty-four mice
were used with 6 mice in each group. Mice were purchased from Harlan
Laboratories and housed in the same manner as in the pilot study. Upon
delivery, mice habituated for 4 days before handling. Protocols were approved
26
by the University of Mississippi Institutional Animal Care and Use Committee
(protocols 07-016,10-026).
Materials and Data Collection
Morris water maze
All materials and methods were similar to the pilot study. I used the same
circular tub as In the pilot study (114.3 cm across x 82 cm high) along with the
same platform (10 cm across x 71 cm high). In the pilot experiment I used black
and white mice and colored both with black markings before testing. Since all
mice to be used in further experiments were white and because the tracking of
the EthoVision software utilizes the contrast of the mouse to its surroundings, I
painted both the tub and platform with black epoxy paint prior to the experiment.
Water height remained 10 cm below the lip of the tub with the water rising 1 cm
above the platform. The poor reflection of light in the black pool hides the
platform so mice are unable to see the platform during trials even though no
coloring was added to the water. Temperature remained 24°C ± 2°C to motivate
mice to locate the platform for escape without inducing hypothermia. The same
cues used in the pilot study for MWM acquisition as well as the same software
and FireWire camera for tracking and collecting data were used in this
experiment. I used EthoVision software to divide the pool into quadrants
designated as Northeast (NE), Southeast (SE), Northwest (NW), and Southwest
(SW). The platform remained in the NW quadrant for all trials except during the
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no-platform and visual platform probes. In training and visual probe trials,
distance to reach the platform; duration of the trial; velocity during acquisition;
and distance, frequency, and latency in each quadrant were measured. In the
no-platform probe distance and duration in all quadrants was collected, along
with velocity within the trial.
Locomotor and exploratory behavior
The day following the last day of water maze testing, animals were
individually placed in activity chambers (San Diego Instruments, CA, USA) where
the locomotor activity was automatically monitored. Total activity was expressed
as the total number of interruptions of 16 x 16 cell photobeams per chamber plus
counts of rearing behavior. Rearing is a more intense locomotor behavior than
walking, during which the mouse rears up on its hind legs breaking a higher
photobeam. Initial activity in the chamber after an acclimation period (20 min) is
considered exploratory (about 10 min) whereas later activity is considered a
measure of locomotor behavior (hyper- or hypo-active or normally active). I
recorded two, 10 min sessions after the acclimation and exploratory period.
Statistical analysis
I analyzed the five days of regular trials and the no-platform probe using
the same methods as In the Pilot Study. I performed a one-way ANOVA to
compare each group’s performance of duration, distance, and velocity In the
visual probe. All statistics were performed using SPSS Statistics 19.0.0.
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Drugs
Mice were given either 3 mg/kg Scopolamine i.p. or 0.9% saline i.p. 20 min
prior to testing over the eight days (Figure 6A). One hour prior to testing on each
of the eight days, I administered either 10 mg/kg Schisandrol A or sterile water
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Figure 6. Chemical Structures, a) Scopolamine, a non-specific mAChR antagonist, it blocks
M1-M5 acetylcholine receptors b) Schizandrol A, an isomer of Schizandrin, a purported
AChE inhibitor. AChE inhibitors prevent the breakdown of ACh at the synapse and enhance
its effective time for signal transmission in the synaptic cleft.
Mice were divided into 4 groups: a control group (Con, n=4, saline +
water). Scopolamine group (Sep, n=6. Scopolamine -1- water), Schisandrol A
group (Sez, n=5, saline -1- Schisandrol A), and a Scopolamine and Schisandrol A
group (SepSez, n=5. Scopolamine + Schisandrol A). Schisandrol A was
purchased from Tengarden (Shanghai, China). Scopolamine hydrobromide was
purchased from the Sigma-Aldrich Company (St. Louis, MO). All groups were
originally n=6, but two controls and one mouse in the SepSez group were
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euthanized due to complications likely related to the oral gavage procedure.
Additionally, one mouse’s data In the Scz group was not used because, unlike all
other mice, he never found the platform prior to 60 sec across training and
consistently floated throughout the trials.
Methods
Morris water maze
Mice underwent seven days of training In the water maze. I placed each
mouse gently Into the pool with its head facing the pool’s wall. Each mouse
underwent four trials each day except on day seven where I ran three trials and
the four probe trials - to be described shortly. Each trial had an inter-trial interval
(ITI) of approximately 20 min. For each trial, mice were released from points
centered In one of four quadrants of the pool and designated N, S, E, or W. I
randomized the order of release at the four points across days, but all mice had
the same order on a given day. Mice were allowed 60 s to find the platform, and
if they did not succeed, I gently guided them to the platform where they remained
for 2 s and they were then removed from the pool, towel dried, and placed in a
drying cage with a towel before being returned to their home cages. On the
seventh day, the fourth trial was replaced by the “no-platform probe”, where the
platform was removed, and the mice had 60 s to explore the maze. Significantly
greater duration and distance within the previously correct quadrant (PCQ)
compared to the other three quadrants of the pool would suggest that the mice
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learned the correct position of the platform during training. After the no platform
probe, I returned the platform to the pool, placed it in the Southwest quadrant.
and drained the water until it reached 1 cm below the level of the platform. I ran
three visually cued probe trials where the mice had 60 s to locate the platform
with an ITI of approximately 20 min as for hidden platform trials.
Locomotor and exploratory behavior
On the eighth day of testing, mice were placed in the open field chamber
for 20 min for acclimation followed by 30 min of monitoring. The first 10 min of
monitoring were considered exploratory behavior, followed by two 10 min
intervals designated locomotor one and locomotor two that measured general
activity. The chamber was thoroughly cleaned with Windex® (S. C. Johnson &
Son, Racine, Wl) after each mouse to ensure no odors from previous subjects
disrupted the mouse’s performance in the task.
Results
Morris water maze
For all results the alpha value was p<0.05. All analyses performed were
repeated measures GLMs using SPSS statistics 19.0.0. All groups showed
some Improvement across days in duration (F (6,11) = 4.42, p<0.01, Figure 7)
and distance (F (6,11) = 10.06 p <0.0006, Figure 8). However, there was a
significant effect of treatment on duration (F (3,16) = 3.47, p<0.04. Figure 7) with
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the ScpScz group taking longer to reach the platform than Con (t(7)=17.58, p<
0.055) or Sep (t(8)=15.56, p<0.06) treated mice at a marginally significant level













Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Figure 7. Average duration to reach the platform across days for treatment groups
in Experiment 1. Groups marked with "A" are significantly different from groups
marked with B.
Similarly, for distance (F (3,16)=9.89, p<0.0006. Figure 8), ScpScz mice
traversed more distance to reach the platform than all other groups (ScpScz vs
Con, p<0.001, ScpScz vs. Sep, p<0.055, ScpScz vs. Sez, p<0.003. Figure 8).
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Figure 8. Average distance to reach the platform across days for treatment groups
in Experiment 1. Groups marked with “A" are significantly different from groups
marked with B.
There were no significant interaction effects. No significant effect of treatment
was seen on velocity: however, velocity of all groups did change over days,
decreasing for the first five days and then increasing a little on day six and seven
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Figure 9. Average velocity across days for treatment groups in
Experiment 1.
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During the no platform probe, a significant difference was seen among

















Figure 10. Average duration in the PCQ during the no-platform probe
for treatment groups in Experiment 1. Groups marked with “A" are
significantly different from groups marked with B.
Tukey-Kramer HSD t-tests revealed the SepSez spent less time in the PCQ than
Con, no other groups differed. In addition, only the controls spent more time in





















Figure 11. Average duration in the no-platform probe in
Experiment 2. Asterisk indicates significance, p<0.05.
Sez
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Latency to the previous platform area, distance in the PCQ, and velocity during
the probe trial did not differ significantly.
One way ANOVA revealed that, during the visual probe, treatment
significantly altered both distance and duration to reach the platform (F(3,16) =
3.82, p<0.03, F(3,16) = 3.69, p<.03. Figure 12A& 12B).
























Figure 12. Average distance and duration to the platform during the visual probe for treatment groups in
Experiment 1. Groups marked with “A” are significantly different from groups marked with B.
Post-hoc analyses revealed that Sez traversed less distance and required less
time to reach the platform than ScpScz in both distance and duration (Figure 12).
No other groups differed significantly. All post-hocs performed were Tukey HSD.
Locomotor and exploratory behavior
In the Open Field Task (OFT) treatment did not affect the exploratory
phase of locomotion. In the first locomotor phase, treatments altered behavior
(F(3,17) = 3.25, p<0.047. Figure 13). The Sop group exhibited hyperactivity
compared to all the other groups (all p’s<0.03. Figure 13). The lack of






















Figure 13. Locomotor activity for treatment groups in Experiment 1. Groups
marked with “A" are significantly different from groups marked with B.
Discussion of Experiment One
Unlike my hypothesis, Schisandrol A (SchisA) did not reverse the memory
impairment caused by the cholinergic antagonist, Scopolamine (Scop). All
groups learned to escape the water onto the hidden platform as seen by the
decrease in duration and distance to reach the platform over days, but not all
groups were as efficient at escape. Interestingly, the mixture of the drugs
enhanced memory deficits as the SepSez took longer duration to reach the
platform than Con and additionally more distance to reach the platform than all
groups. There are many non-spatial strategies mice can use to reach the
platform. The no-platform probe tells us if the mice utilized a spatial strategy,
indicated by the search for the platform in its previous location. In the no
platform probe, SepSez spent less time in the PCQ than Con suggesting they did
not learn the spatial location of the platform in the regular trials as well as
controls. No other groups differed. Even though no significant differences
36
existed in distance to the platform during the no-platform probe, the significant
difference in duration is a good indicator of learning because no differences in
velocity were observed between groups. Thus, only Con learned the location of
the platform suggesting that SchisA does not improve spatial learning and that
adding SchisA to an organism that already has reduced cholinergic function may
even impair performance compared to controls and other groups rather than
improving spatial learning.
Despite SchlsA’s lack of enhancement in spatial memory, it may have
Improved a simple stimulus/response association because the Scz group was
faster and swam less distance to reach the visible platform than the ScpScz
group during the visual probe. Whether this result further emphasizes the poor
performance of the combined drug group or suggests SchisA might actually
Improve visual cue learning is difficult to say given that Scz Is only different from
the combined group but not different from Sep and Con. It does suggest that
SchisA alone is not detrimental to visual learning in the way the combined drug
is. Although the SchisA did not improve spatial learning, it does seem to reverse
hyperactivity induced by Scop as seen by the significant reduction of locomotor
activity caused by Scop in the group given Scop and Schiz. SchisA alone did not
alter locomotor activity.
Because SchisA does not help memory In Impaired mice and seems to
have potent negative effects in combination with the ACh antagonist. Scop, it
does not seem to be a viable option for diseases that cause Impairments In the
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cholinergic system. Therefore, I do not recommend further testing of this drug for
investigation in memory improvement. If the cholinergic system is not damaged,
SchisA may improve visual cue learning, or SchisA given to people with a normal
cholinergic system will not cause damage to visual cue learning as the combined
drug does. However, SchisA alone does not allow for spatial learning as neither
Sep, Sez, or the combined group showed a preference for the PCQ after training
in the MWM whereas controls did. Thus, any gains in reduced side effects of
poor cholinergic function on locomotor activity and any gains in improved visual
cue learning would be offset by a reduction in spatial memory. Therefore, I would
not recommend use of SchisA by cholinergic deficient or cholinergic intact
humans.
I expected to find positive effects for SchisA on learning and memory or at
the very least that SchisA would reduce negative effects of Scop. However, I
instead found that the combined drug group was worse than other groups on
several measures. Another oddity was that there was not a stronger negative
effect of Scop for the SchisA to Improve. The fact that the SchisA could not
improve a dose of Scop that did not cause a strong deficit suggests SchisA does
not improve learning and memory, and it also calls into questions the efficacy of
Scop. I did find that Scop caused hyperactivity and prevented spatial learning, as
there was no preference for the PCQ In the no-platform probe. However, Sep
animals did not have significantly reduced search time in the PCQ compared to
controls and did not have impaired learning of basic escape strategies in the
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MWM compared to Con. This result is surprising because of the bulk of evidence
suggesting a role for Scop in spatial learning and memory (Klinkenberg et al.
2010, Masuoka et al. 2006, Egashira 2008, Berger-Sweeney et al. 1995,
Deianna et al. 2009) and specifically deficits In acquisition of the Morris water
maze task (Deianna et al. 2009, Klinkenberg et al. 2010, Berger-Sweeney et al.
1995). To make sure that Swiss Webster mice used In our labs do show typical
deficits that can be caused by anticholinergics,  I Increased the dose of Scop used
in Experiment 1 and also tested the effects of a second anticholinergic, Atropine
Sulfate, on water maze performance.
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Experiment 2
Given that Scopolamine (Scop) at 0.5mg/kg did not produce a deficit in
MWM acquisition in Experiment 1, I set out to determine If a higher dose of Scop
would affect subjects’ abilities to learn how to escape to the hidden platform and
use spatial strategies in the MWM as in previous animal studies (Klinkenberg et
al. 2010, Masuoka et al. 2006, Egashira 2008, Berger-Sweeney et al. 1995,
Delanna et al. 2009) and alter locomotor behavior (Klinkenberg et al. 2010).
Additionally, I wanted to compare the original anticholinergic used, Scop, with
another ACh antagonist. Atropine Sulfate (AS), to see if Impairments in spatial
learning and locomotor alterations would occur in the Swiss Webster mice as
seen in rats and other mouse strains. I hypothesized that a higher dose of Scop
than used In Experiment 1 and AS at 20 mg/kg would impair both acquisition and
spatial learning in the Morris water maze (MWM) and alter locomotion.
Methods and materials
Animals
I used 7 - 8 week old naive, male Swiss Webster mice. 30 mice were
used with 10 mice in each group. Mice were purchased from Harlan Laboratories
and housed in the same manner as in the pilot study. Upon delivery, mice
habituated for four days before handling. Protocols were approved by the
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University of Mississippi Institutional Animal Care and Use Committee (protocols
07-016. 10-026).
Materials and data collection
Morris water maze
The same circular tub (114.3 cm across x 82 cm high) and platform (10
cm across x 71 cm high) were used as in Experiment 1. Additionally, the same
parameters and software were used to collect data from the MWM trials. The
hidden platform remained in the Northwest quadrant during regular trials, and I
moved It to the Southwest quadrant for the visual probe.
Locomotor and exploratory behavior
Materials and data collection were identical to Experiment 1.
Statistical Analysis
All analyses remained the same as In Experiment 1.
Drugs
Mice were given either 3 mg/kg Scop i.p. (Figure 14A), 20 mg/kg AS l.p.
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Figure 14. Chemical structures of a) Scopolamine and b) Atropine Sulfate. Both
chemicals block ACh from binding to mAChR and inhibit cholinergic pathways involved in
learning and memory.
Scop and AS were purchased from the Sigma-Aldrich Company (St. Louis, MO).
Mice were divided into three groups: a control group (Con, n=10, saline).
Scopolamine group (Scop, n=9. Scopolamine), and an Atropine Sulfate group
(Atropine, n=10. Atropine Sulfate). One mouse in the Scop group was
euthanized due to undetermined neurological complications on arrival in the lab.
Methods
Morris water maze
As in Experiment 1, mice underwent four 60 s trials daily from four
randomized start points. Each mouse had an ITI of 20 min, and no mouse
entered the same start location twice on the same day. A difference between
Experiment 1 and Experiment 2 was that no pre-training trial was performed on
day one in Experiment 2. On the seventh day, I removed the platform during trial
four to assess if the mice had learned the location of the platform in the PCQ.
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Also, instead of three visual trials on the seventh day, I performed a single visual
probe as a fifth trial on day seven, where the platform was moved to the
Southwest quadrant. As previously, I drained the water In the pool to 1 cm below
the platfornn, but no flag was used to indicate the platform’s location. Mice were
allowed 60 s to reach the visible platform. If the mouse did not locate the
platform, I gently guided it to the location.
Locomotor and exploratory behavior
On the eighth day of testing, mice were placed in an open field chamber
for 30 min as in Experiment 1. The same equipment and protocols were used as
In Experiment 1 with the exception that a computer failure during the 10 min




Using a General Linear Model procedure, I revealed that distance.
duration, and velocity Improved over days demonstrating overall learning for the
location of the platform across groups (Distance: F(6,156) = 9.785, p<0.0001,
Figure 15A, Duration: F(6,156) = 8.36, p<0.0001. Figure 15B, Velocity: F(6,156)
= 9.11, p<0.0001, Figuer 15C). Tukey HSD post-hoc analysis showed that Scop
required longer distance to reach the platform than both Atropine and Con
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(p<0.004, p<0.0001, Figure 15A). Also, Controls required less time than Atropine
and Scop to reach the platform (p<0.005, p<0.02, Figure 15B). Additionallyj
Scop had significantly faster velocity when compared to AS (p<0.001, Figure
15C). While the Scop mice had a similar duration to the platform as the AS mice,
they also swam a greater distance at an increased velocity compared to the AS
mice. Thus, the Scop mice must have been swimming quickly to all the wrong
places, arriving at the platform at a similar time as the slow and more direct
swimming of Controls and AS mice (Figure 15).
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Figure 15. Average distance, duration, and velocity across days in Experiment 2. Groups marked with
"A” are significantly different from groups marked with B.
In the no-platform probe trial there was a significant difference for treatment in
both distance and frequency of crosses in the four quadrants of the maze
(F(2,26) = 6,896, p<0.004. Figure 16A, F(2,26) = 5.672, p<0.009. Figure 16C).
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Despite the similar performance of AS treated mice to controls in distance to
reach the platform during training, the Atropine mice had no preference for the
PCQ in duration, distance, or frequency of crosses (Figure 16) and thus did not
learn a spatial strategy. Scop showed a greater preference for the SW and NW
quadrants than the PCQ quadrant in distance swam in the quadrant and a
greater preference for the SW quadrant over the PCQ for frequency of crosses
(Post-hoc Pairwise Comparison, Bonferroni corrected. Figure 16A & 16C). The
Con preferred the PCQ to the SW and NW quadrants for distance swam and a
preference for the PCQ over the SW quadrant in duration spent in the quadrants
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Figure 16, Average distance, duration, and frequency in no-platform probe in Experiment 2. Groups marked with "A’
are significantly different from groups marked with B.
There was a significant interaction between quadrant and treatment in distance
(F(6,78)=3.212, p<0.007), likely due to the Scop mice having a preference for a
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quadrant other than the PCQ, the controls preferring the PCQ, and the AS mice
having no preference. These results support the interpretation that the Scop and
AS mice learned the maze by a non-spatial strategy. These groups may have
laarned the task by circling at the distance the previous platform was located
from the wall or by swimming in loops. In doing so they became more efficient at
©scaping the maze but were unable to learn the actual spatial location of the
probe. Thus, when the platform was removed they did not continue to search for
it in the PCQ. Because I ran a single no-platform probe trial during which the
mice were released from the N release point, all mice had to swim through the
NE quadrant to reach the PCQ. This might explain the lack of significance
between the PCQ and the NE quadrant for controls.
For the visual probe, I did not see a treatment effect for duration swam in
the four quadrants (Figure 17A). Since this test violated the assumption of
homogeneity of variation between treatment groups (Levene’s Test, p = 0.001), I
also compared duration swam in the PCQ with a non-parametric Kruskal-Wallis
test. The non-parametric test also showed no significant treatment effect.


































Figure 17. Average duration, distance, and velocity in the visual platform probe in Experiment 2.
Groups marked with “A" are significantly different from groups marked with B.
However, I did find a significant treatment effect for velocity, as in the training
trials (F(2,26) = 6.362, p<0.006. Figure 17C). Post-hoc analyses revealed that
Scop swam faster than both Atropine (p<0.001) and Con (p<0.04. Figure 17C).
Locomotor and exploratory behavior
Although I have not completed analyses for the locomotor chamber, the
data examined thus far suggest that Atropine animals were far less active than
the other two groups.
Discussion of Experiment 2
The higher dose of Scop used in Experiment 2 versus Experiment 1
resulted in the expected impairments in acquisition of the MWM as seen by the
longer distance and duration over days to reach the platform by Scop mice
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compared to controls. Additionally, hyperactivity was observed in the Scop
treated mice as seen by the increased velocity over days of the training trials and
in the visual probe. In the no-platform probe, Scop did not spend a significantly
longer time in the PCQ. Interestingly, they traversed longer distance and
frequented the NW quadrant more often than the PCQ, which signifies that they
had developed a method of finding the platform that resulted in persistently
searching a non-PCQ quadrant instead of using spatial ability to complete the
task. They may also have persistently searched this quadrant because this is the
quadrant closest to where I was standing. Having not found the platform using
trial-and-error or whatever non-spatial method they were using, they may have
then swam to the experimenter expecting escape to result, as the experimenter
does retrieve them from the pool at the end of each trial.
Atropine animals appeared to be more efficient than Scop mice at locating
the platform during the training trials as they were more similar to controls in
distance to reach to platform during training. However, as for Scop animals.
Atropine animals also had impairment in spatial learning as evidenced by a lack
of preference for the PCQ or any other quadrant during the no-platform probe.
Interestingly, at least at the doses given, AS and Scop appeared to have
opposite motor effects. AS causes a decrease in motor activity as seen in the
slow velocity during training trials and the visual platform probe compared to
Scop animals. I expect results from the locomotor chamber to back up the
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In my experiments, I found that the outbred Swiss Webster and CD1 mice
could learn the position of the hidden platform In the MWM although they were
not as efficient learners as inbred C57 mice, which are thought to have an
advantage in the spatial maze due to breeding for Improved cognition, resulting
in hippocampal specializations (Ingram et al. 1980, Nguyen et al. 2000, Sung et
al. 2008). Outbred mice are often used if cost is  a concern (typically an outbred
strain such as the Swiss Webster or GDI). I found that such outbred strains are
adequate performers in the MWM. Having validated their use in the MWM, I
chose to use an outbred strain, to examine the effects of natural products on
cognition, because of their low cost, their common use In studies In the University
of Mississippi’s COBRE unit, and their shown superiority to CD1 In multiple
memory tasks (Kuc et al. 2006, Augustsson 2004).
In Swiss Webster mice, I found that Schisandrol A (SchlsA) does not
improve spatial learning and memory impairments and in fact my have a negative
effect on cognition In an already susceptible system. However, SchisA may
Improve visual learning and counteracts hyperactivity induced by Scopolamine
(Scop). The chemical may be working as an AChE inhibitor or by some other
biochemical mechanism unknown at this time. During the probe trial. Scop mice
did not preferentially search the PCQ compared to other quadrants however,
their impairment in searching the PCQ was not significantly worse than controls.
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To confirm that Scop does interfere with spatial learning and memory in
Swiss Webster mice as it does in rats and other mice strains (Klinkenberg et al.
2010, Egashira et al. 2008, Kohler et al. 1996, Deianna et al. 2009, Powers et al.
2009, Berger-Sweeney et al. 1995, Kuc et al. 2006), I performed a second
experiment. In Experiment 2, I sought to confirm, that the anticholinergics.
Scopolamine and Atropine Sulfate, have the suggested effects on spatial
learning (Brufani et. al 1987, Egashira etal. 2008, Kohler etal. 1996, Deianna et
al. 2009, Kuc et al. 2006, Klinkenberg et al. 2010). I tested a higher dose of
Scop and a typical moderate dose of Atropine Sulfate (AS), and observed that
both anticholinergics had similar effects on learning and memory; however, they
appeared to have opposite effects on motor activity at the dose of AS and Scop
given.
Because results of Experiment 2 revealed both anticholinergics worked as
expected, a higher dose of Scop may have Increased the differences between
controls and Scop treated animals In Experiment 1; however, it would not have
affected the way Scop and SchisA impaired animals. In fact the lower dose of
Scop used should have made SchisA, if It was going to work, reverse the
impairments caused by Scop more easily.
In Egashira et al.’s (2008) study, a stereoisomer of SchisA, Schizandrin,
reversed memory Impairment induced by Scop. Although the stereoisomer I
used did not produce the same improvements in memory as Schizandrin, SchisA
did decrease hyperactivity induced by Scop as seen in Egashira et al. (2008).
Since these chemicals appear to work similarly on hyperactivity,  I wonder If a
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methodological difference in my cognitive tasks could have contributed to
opposing results. One explanation for the conflicting result may be that they
used an 8-arm radial maze to test spatial ability while I used the MWM to test for
deficits in spatial learning. The 8-arm radial maze can be solved using working
memory or even visual cue learning if the alleys have any minor differences in
appearance. However, subjects cannot solve the MWM without spatial memory.
If the rats in Egashira et al. (2008) did use working memory to successfully
complete the task, the possible enhancement In visual cue memory observed by
SchisA may have been due to enhancement in working memory and not spatial
memory. AChE Inhibitors have been shown In other studies to reverse working
memory deficits Induced by Scop (Xiong et al. 1995, Csernansky et al. 2005).
This further supports the proposal that SchisA did not act as a learning enhancer
but possibly only enhanced visually cued memory in both Egashira et al. (2008)
and in the present study.
While there are some benefits of SchisA, it appears that if a deficit is
already present within the cholinergic system, the addition of SchisA can
compound the deficiency in learning and memory. Because Egashira et al.
(2008) suggested that Schizandrin was an AChE inhibitor, I believed SchisA
might also exhibit AChE inhibition properties. I have since found evidence that
contradicts this assumption (Hung et al. 2007) showing no AChE activity for
either of these drugs. Because this drug does not seem to work via AChE
inhibition, it is unlikely to be a proper treatment option for aging or Alzheimer’s
disease patients. The fact that SchisA does reducing the hyperactivity induced
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by Scop begs the question of how this drug is working to counter the effects. In
addition, the negative combinatorial effects of SchisA with Scop on cognition
suggest this drug does have an interaction with the ACh receptors. Future
studies should focus on the biochemistry of SchisA/ACh receptor interactions.
Although SchlsA does not seem to improve complex cognitive processes
such as spatial memory, Schisandra chinensis contains many compounds that
may improve cognition, especially in the cholinergic system. A study done to
assess the AChE inhibitory effects of various components in the fruit showed a
difference in activity of various compounds (Hung et al. 2007). Additionally, a
component of the fruit, gomisin A, was found to reverse Scop impairments in the
passive avoidance test (Kim et al. 2006). Further research needs to be
performed on the various constitutes before the whole fruit is deemed an
ineffective treatment option for cholinergic deficiency.
Conclusion
Through my experiments I found that SchisA cannot currently be
recommend as a cholinergic memory enhancer or a treatment for cholinergic
deficiency due to Its lack of spatial memory improvement and further impairment
of a damaged cholinergic system. Swiss Webster mice are an adequate model
for testing these types of drugs due to their ability to complete the MWM task
using spatial strategies and given the expected effects of cholinergic antagonist
In the MWM and locomotor chamber. To see potent effects on acquisition and
spatial memory In the MWM, a higher dose than 3 mg/kg of Scop should be
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used, but the 20 mg/kg dose of AS should be avoided due to the severe motor
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